Learning Objectives:

At the conclusion of this activity, participants will be able to:

  1.  To understand risk factors for development of endometrial hyperplasia and malignancy
  2. To review data to support fertility-preserving treatment of endometrial hyperplasia and malignancy
  3. To understand success rates of fertility-preserving treatment of endometrial hyperplasia and malignancy
Session date: 
04/06/2022 - 8:00am to 9:00am CDT
Location: 
Burch Building, Basement Conference Room
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Elena Moore, MD